Yiming Xu

1.8k citations
49 papers · 1.4k indexed · 1 hit paper · h-index 17
Topics
Inflammasome and immune disorders (12 papers)Carbohydrate Chemistry and Synthesis (6 papers)Synthesis of heterocyclic compounds (6 papers)

In The Last Decade

Yiming Xu

49 papers receiving 1.4k citations

Hit Papers

The NLRP3 Inflammasome Pathway: A Review of Mechanisms an...20222026202320242022100200300

Peers

Yiming Xu
Comparison fields: 5 of 106
  • Molecular Biology 634
  • Organic Chemistry 627
  • Immunology 130
  • Pharmacology 120
  • Biological Psychiatry 78
Replace Xiangbao Meng with:
Xiangbao Meng China
Xiang‐Yang Ye China
Hwayoung Yun South Korea
Jian-Shu Lou China
Li-Fang Yu China
Yuepiao Cai China
Maris A. Cinelli United States
Jianhong Yang China
Zheying Zhu United Kingdom
Yiming Xu relative to Xiangbao Meng China Xiangbao Meng's profile →
Citations per field
00.5×1.5×1.8×
Xiangbao Meng · 1×
Citations per year

Countries citing papers authored by Yiming Xu

Since Specialization
Citations

This map shows the geographic impact of Yiming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Xu more than expected).

Fields of papers citing papers by Yiming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Xu. The network helps show where Yiming Xu may publish in the future.

Co-authorship network of co-authors of Yiming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiming Xu. A scholar is included among the top collaborators of Yiming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiming Xu. Yiming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 3
4 2
5 1
6 7
7 17
8 9
9 2
10 19
11 13
12 155
13 159
14 15
15 13
16 56
17 13
18 13
19 9
20 8

About Yiming Xu

Yiming Xu is a scholar working on Biological Psychiatry, Toxicology and Organic Chemistry, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (12 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Synthesis of heterocyclic compounds (6 papers). The work is most often cited by research in Biological Psychiatry (78 citations), Organic Chemistry (627 citations) and Toxicology (51 citations). Yiming Xu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Shijun Zhang, Hallie Blevins, Savannah Biby, Lisheng Wang, Haroon Ur Rashid, Yaseen Muhammad, Wei‐Shan Zhou, Jun Jiang, Nasir Ahmad and Lixin Liao. Their work appears in journals such as The FASEB Journal, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026